Douglas Losordo
2023 - Cadrenal Therapeutics
In 2023, Douglas Losordo earned a total compensation of $528.7K as Chief Medical Officer at Cadrenal Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
| Bonus | $119,128 |
|---|---|
| Salary | $401,026 |
| Other | $8,536 |
| Total | $528,690 |
Losordo received $401K in salary, accounting for 76% of the total pay in 2023.
Losordo also received $119.1K in bonus and $8.5K in other compensation.
Rankings
In 2023, Douglas Losordo's compensation ranked 1,943rd out of 2,918 executives tracked by ExecPay. In other words, Losordo earned more than 33.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,943 out of 2,918 | 33rd |
Division Manufacturing | 1,114 out of 1,608 | 31st |
Major group Chemicals And Allied Products | 687 out of 901 | 24th |
Industry group Drugs | 670 out of 864 | 23rd |
Industry Pharmaceutical Preparations | 480 out of 622 | 23rd |
Source: SEC filing on June 11, 2024.
Losordo's colleagues
We found two more compensation records of executives who worked with Douglas Losordo at Cadrenal Therapeutics in 2023.